Mechanisms underlying the autonomic modulation of ventricular fibrillation initiation—tentative prophylactic properties of vagus nerve stimulation on malignant arrhythmias in heart failure

Classical physiology teaches that vagal post-ganglionic nerves modulate the heart via acetylcholine acting at muscarinic receptors, whilst it is accepted that vagus nerve stimulation (VNS) slows heart rate, atrioventricular conduction and decreases atrial contraction; there is continued controversy as to whether the vagus has any significant direct effect on ventricular performance. Despite this, there is a significant body of evidence from experimental and clinical studies, demonstrating that the vagus nerve has an anti-arrhythmic action, protecting against induced and spontaneously occurring ventricular arrhythmias. Over 100 years ago Einbrodt first demonstrated that direct cervical VNS significantly increased the threshold for experimentally induced ventricular fibrillation. A large body of evidence has subsequently been collected supporting the existence of an anti-arrhythmic effect of the vagus on the ventricle. The development of prognostic indicators of heart rate variability and baroreceptor reflex sensitivity—measures of parasympathetic tone and reflex activation respectively—and the more recent interest in chronic VNS therapy are a direct consequence of the earlier experimental studies. Despite this, mechanisms underlying the anti-arrhythmic actions of the vagus nerve have not been fully characterised and are not well understood. This review summarises historical and recently published data to highlight the importance of this powerful endogenous protective phenomenon.

[1]  J. Coote,et al.  Direct evidence of nitric oxide release from neuronal nitric oxide synthase activation in the left ventricle as a result of cervical vagus nerve stimulation , 2009, The Journal of physiology.

[2]  M. Sugimachi,et al.  Vagal stimulation markedly suppresses arrhythmias in conscious rats with chronic heart failure after myocardial infarction , 2005, 2005 IEEE Engineering in Medicine and Biology 27th Annual Conference.

[3]  K. Umeno,et al.  Time course of sympathovagal imbalance and left ventricular dysfunction in conscious dogs with heart failure. , 1998, Journal of applied physiology.

[4]  Nicola Montano,et al.  Respiratory-related heart rate variability in progressive experimental heart failure. , 2005, American journal of physiology. Heart and circulatory physiology.

[5]  J. Balligand,et al.  Nitric Oxide and Cardiac Function: Ten Years After, and Continuing , 2003, Circulation research.

[6]  D. Chialvo,et al.  Electrical Restitution, Critical Mass, and the Riddle of Fibrillation , 1999, Journal of cardiovascular electrophysiology.

[7]  M. N. Levy,et al.  Sinus and atrioventricular nodal distribution of sympathetic fibers that contain neuropeptide Y. , 1990, Circulation research.

[8]  M. N. Levy,et al.  Inhibition of Cardiac Vagal Effects by Neurally Released and Exogenous Neuropeptide Y , 1989, Circulation research.

[9]  Kapil Kumar,et al.  Potent antifibrillatory effects of intrapericardial nitroglycerin in the ischemic porcine heart. , 2003, Journal of the American College of Cardiology.

[10]  J. Papp,et al.  Electrophysiological effects of ivabradine in dog and human cardiac preparations: potential antiarrhythmic actions. , 2011, European journal of pharmacology.

[11]  L. Rohde,et al.  Cholinergic stimulation with pyridostigmine reduces ventricular arrhythmia and enhances heart rate variability in heart failure. , 2003, American heart journal.

[12]  H. L. Stone,et al.  Autonomic mechanisms in ventricular fibrillation induced by myocardial ischemia during exercise in dogs with healed myocardial infarction. An experimental preparation for sudden cardiac death. , 1984, Circulation.

[13]  A. Camm,et al.  Risk stratification for arrhythmic events in postinfarction patients based on heart rate variability, ambulatory electrocardiographic variables and the signal-averaged electrocardiogram. , 1991, Journal of the American College of Cardiology.

[14]  S. Epstein,et al.  Influence of Atropine and of Vagally Mediated Bradycardia on the Occurrence of Ventricular Arrhythmias following Acute Coronary Occlusion in Closed‐Chest Dogs , 1973, Circulation.

[15]  M. N. Levy,et al.  Neuropeptide Y as a Putative Modulator of the Vagal Effects on Heart Rate , 1989, Circulation research.

[16]  S. Priori,et al.  Protective Effect of Vagal Stimulation on Reperfusion Arrhythmias in Cats , 1987, Circulation research.

[17]  Y. H. Zhang,et al.  Suppressing sympathetic activation with clonidine on ventricular arrhythmias in congestive heart failure. , 1998, International journal of cardiology.

[18]  P. Schwartz,et al.  Baroreflex sensitivity, clinical correlates, and cardiovascular mortality among patients with a first myocardial infarction. A prospective study. , 1988, Circulation.

[19]  S. S. Hull,et al.  Vagal reflexes and survival during acute myocardial ischemia in conscious dogs with healed myocardial infarction. , 1991, The American journal of physiology.

[20]  J. Coote,et al.  Differential cardiac responses to unilateral sympathetic nerve stimulation in the isolated innervated rabbit heart , 2012, Autonomic Neuroscience.

[21]  Y. Furukawa,et al.  Cardiac responses to VIP and VIP-ergic-cholinergic interaction in isolated dog heart preparations. , 1990, European journal of pharmacology.

[22]  A J Camm,et al.  Prognostic value of baroreflex sensitivity testing after acute myocardial infarction. , 1992, British heart journal.

[23]  M. Dunlap,et al.  Evidence for impaired vagus nerve activity in heart failure , 2011, Heart Failure Reviews.

[24]  E. Potter Neuropeptide Y as an autonomic neurotransmitter. , 1988, Pharmacology & therapeutics.

[25]  J. Nolasco,et al.  A graphic method for the study of alternation in cardiac action potentials. , 1968, Journal of applied physiology.

[26]  D. Paterson,et al.  Pre-synaptic NO-cGMP pathway modulates vagal control of heart rate in isolated adult guinea pig atria. , 2000, Journal of molecular and cellular cardiology.

[27]  R Dietz,et al.  Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. , 2000, JAMA.

[28]  J. Wess,et al.  M2 and M4 Receptor Knockout Mice: Muscarinic Receptor Function in Cardiac and Smooth Muscle In Vitro , 2000 .

[29]  A. Feldman,et al.  Morphological and functional changes in cardiac myocytes isolated from mice overexpressing TNF-alpha. , 2003, American journal of physiology. Heart and circulatory physiology.

[30]  J. Jalife,et al.  Morphologic pattern of the intrinsic ganglionated nerve plexus in mouse heart. , 2011, Heart rhythm.

[31]  D. Corrado,et al.  Sudden cardiac death in young people with apparently normal heart. , 2001, Cardiovascular research.

[32]  K. Kent,et al.  Electrical Stability of Acutely Ischemic Myocardium: Influences of Heart Rate and Vagal Stimulation , 1973, Circulation.

[33]  A. Samaan The antagonistic cardiac nerves and heart rate. , 2022, Journal of Physiology.

[34]  P. Schwartz,et al.  The autonomic nervous system and sudden death. , 1998, European heart journal.

[35]  S. Dhein,et al.  Muscarinic receptors in the mammalian heart. , 2001, Pharmacological research.

[36]  J. Coote,et al.  Autonomic modulation of electrical restitution, alternans and ventricular fibrillation initiation in the isolated heart. , 2007, Cardiovascular research.

[37]  S Capewell,et al.  Decreased cardiac parasympathetic activity in chronic heart failure and its relation to left ventricular function. , 1992, British heart journal.

[38]  F. X. Guix,et al.  The physiology and pathophysiology of nitric oxide in the brain , 2005, Progress in Neurobiology.

[39]  M. N. Levy,et al.  Effect of Enhanced Contractility on the Left Ventricular Response to Vagus Nerve Stimulation in Dogs , 1969, Circulation research.

[40]  E. Vester,et al.  Entzündung des Myokards als Arrhythmietrigger , 2000, Zeitschrift für Kardiologie.

[41]  A Garfinkel,et al.  Ventricular Fibrillation: How Do We Stop the Waves From Breaking? , 2000, Circulation research.

[42]  G. Mancia,et al.  Sympathetic and reflex abnormalities in heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy. , 2001, Clinical science.

[43]  D. Paterson,et al.  Neuropeptide Y reduces acetylcholine release and vagal bradycardia via a Y2 receptor-mediated, protein kinase C-dependent pathway. , 2008, Journal of molecular and cellular cardiology.

[44]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[45]  M. Caron,et al.  Beta-adrenergic receptors: biochemical mechanisms of physiological regulation. , 1984, Physiological reviews.

[46]  Kevin J. Tracey,et al.  The inflammatory reflex , 2002, Nature.

[47]  J. Balligand,et al.  Nitric oxide and cardiac function. , 1996, Circulation research.

[48]  D. Pauza,et al.  Morphology of the Intrinsic Cardiac Nervous System in the Dog: A Whole-Mount Study Employing Histochemical Staining with Acetylcholinesterase , 2003, Cells Tissues Organs.

[49]  P. Schauerte,et al.  Epicardial neural ganglionated plexus of ovine heart: anatomic basis for experimental cardiac electrophysiology and nerve protective cardiac surgery. , 2010, Heart rhythm.

[50]  J. Brown,et al.  Presynaptic modulation of acetylcholine release from cardiac parasympathetic neurons. , 1985, The American journal of physiology.

[51]  R. J. Harman,et al.  National Institute for clinical excellence preoperative tests: Is the consensus hard to get?: 1AP3-9 , 2007 .

[52]  P. Schwartz,et al.  Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death. , 1991, Circulation research.

[53]  D. Pauza,et al.  Architecture and age-related analysis of the neuronal number of the guinea pig intrinsic cardiac nerve plexus. , 2005, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[54]  J. Coote,et al.  Nitric oxide mediates the vagal protective effect on ventricular fibrillation via effects on action potential duration restitution in the rabbit heart , 2007, The Journal of physiology.

[55]  N. Westerhof,et al.  Nitric oxide and cardiac function. , 2007, Life sciences.

[56]  J. Coote,et al.  Vagus nerve stimulation protects against ventricular fibrillation independent of muscarinic receptor activation. , 2011, Cardiovascular research.

[57]  P. Pagé,et al.  Localization of multiple neurotransmitters in surgically derived specimens of human atrial ganglia , 2009, Neuroscience.

[58]  K. Muramoto,et al.  Efferent Vagal Nerve Stimulation Protects Heart Against Ischemia-Induced Arrhythmias by Preserving Connexin43 Protein , 2005, Circulation.

[59]  R. Baisden,et al.  Localization of muscarinic receptor mRNAs in rat heart and intrinsic cardiac ganglia by in situ hybridization. , 1994, Circulation research.

[60]  G. Salama,et al.  Autonomic Nerve Stimulation Reverses Ventricular Repolarization Sequence in Rabbit Hearts , 2007, Circulation research.

[61]  J. Fleiss,et al.  Frequency Domain Measures of Heart Period Variability and Mortality After Myocardial Infarction , 1992, Circulation.

[62]  H. Sabbah,et al.  744 Long-term therapy with neuroselective electric Vagus nerve stimulation improves LV function and attenuates global LV remodelling in dogs with chronic heart failure , 2005 .

[63]  J. Han,et al.  Effects of vagal stimulation, atropine, and propranolol on fibrillation threshold of normal and ischemic ventricles. , 1977, American Heart Journal.

[64]  G. Salama,et al.  Electrical remodeling of cardiac myocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. , 2006, American journal of physiology. Heart and circulatory physiology.

[65]  M. N. Levy,et al.  Effect of Vagal Stimulation on the Overflow of Norepinephrine into the Coronary Sinus during Cardiac Sympathetic Nerve Stimulation in the Dog , 1976, Circulation research.

[66]  N. B. Strydom,et al.  The influence of boot weight on the energy expenditure of men walking on a treadmill and climbing steps , 2004, Internationale Zeitschrift für angewandte Physiologie einschließlich Arbeitsphysiologie.

[67]  S. Weidmann,et al.  The electrical constants of Purkinje fibres , 1952, The Journal of physiology.

[68]  Yanjie Lu,et al.  Choline produces antiarrhythmic actions in animal models by cardiac M3 receptors: improvement of intracellular Ca2+ handling as a common mechanism. , 2008, Canadian journal of physiology and pharmacology.

[69]  P. Corr,et al.  Role of the Vagus Nerves in the Cardiovascular Changes Induced by Coronary Occlusion , 1974, Circulation.

[70]  C. Kidd,et al.  Neuronal nitric oxide facilitates vagal chronotropic and dromotropic actions on the heart. , 1999, Journal of the autonomic nervous system.

[71]  K. Yano,et al.  Histological study on the distribution of autonomic nerves in the human heart , 2003, Heart and Vessels.

[72]  Bramahn . Singh,et al.  Controlling Cardiac Arrhythmias by Lengthening Repolarization: Rationale from Experimental Findings and Clinical Considerations a , 1992, Annals of the New York Academy of Sciences.

[73]  Roberto Maestri,et al.  Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era. , 2009, Journal of the American College of Cardiology.

[74]  S. Snyder,et al.  Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. , 1998, The Journal of clinical investigation.

[75]  A Garfinkel,et al.  Spatiotemporal heterogeneity in the induction of ventricular fibrillation by rapid pacing: importance of cardiac restitution properties. , 1999, Circulation research.

[76]  Zoran B. Popović,et al.  Chronic Vagus Nerve Stimulation Improves Autonomic Control and Attenuates Systemic Inflammation and Heart Failure Progression in a Canine High-Rate Pacing Model , 2009, Circulation. Heart failure.

[77]  A. Gerdes,et al.  Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodeling. , 1999, Journal of molecular and cellular cardiology.

[78]  K. Malik,et al.  Effect of M2 muscarinic receptor antagonist 4-DAMP, on prostaglandin synthesis and mechanical function in the isolated rabbit heart. , 1989, General pharmacology.

[79]  G. Bricca,et al.  Ivabradine Induces an Increase in Ventricular Fibrillation Threshold During Acute Myocardial Ischemia: An Experimental Study , 2008, Journal of cardiovascular pharmacology.

[80]  Hui-zhen Wang,et al.  M3-R/IK(M3)--a new target of antiarrhythmic agents. , 2005, Yao xue xue bao = Acta pharmaceutica Sinica.

[81]  A. Samaan The antagonistic cardiac nerves and heart rate 1 , 1935 .

[82]  H. Crijns,et al.  Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment. , 1994, British heart journal.

[83]  R. Gilmour,et al.  Electrical restitution and spatiotemporal organization during ventricular fibrillation. , 1999, Circulation research.

[84]  B. Surawicz,et al.  Characteristics and Possible Mechanism of Ventricular Arrhythmia Dependent on the Dispersion of Action Potential Durations , 1983, Circulation.

[85]  R. Marshall,et al.  Effects of antiarrhythmic drugs on ventricular fibrillation thresholds of normal and ischaemic myocardium in the anaesthetized rat , 1983, British journal of pharmacology.

[86]  J. Jalife,et al.  Immunohistochemical characterization of the intrinsic cardiac neural plexus in whole-mount mouse heart preparations. , 2011, Heart rhythm.

[87]  J. Coote,et al.  Interaction between direct sympathetic and vagus nerve stimulation on heart rate in the isolated rabbit heart , 2004, Experimental physiology.

[88]  I. Zucker,et al.  Central gain of the cardiac sympathetic afferent reflex in dogs with heart failure. , 1997, The American journal of physiology.

[89]  T. LeJemtel,et al.  High prevalence of nonsustained ventricular tachycardia in severe congestive heart failure. , 1984, American heart journal.

[90]  Chaoqian Xu,et al.  Overexpression of M3 Muscarinic Receptor Is a Novel Strategy for Preventing Sudden Cardiac Death in Transgenic Mice , 2011, Molecular medicine.

[91]  V. Shusterman,et al.  Calcium-dependent arrhythmias in transgenic mice with heart failure. , 2003, American journal of physiology. Heart and circulatory physiology.

[92]  D. Pauza,et al.  Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart , 2000, The Anatomical record.

[93]  J. Coote,et al.  Vagus nerve stimulation inhibits the increase in Ca2+ transient and left ventricular force caused by sympathetic nerve stimulation but has no direct effects alone – epicardial Ca2+ fluorescence studies using fura‐2 AM in the isolated innervated beating rabbit heart , 2010, Experimental physiology.

[94]  J. Coote,et al.  Effects of Direct Sympathetic and Vagus Nerve Stimulation on the Physiology of the Whole Heart – A Novel Model of Isolated Langendorff Perfused Rabbit Heart with Intact Dual Autonomic Innervation , 2001, Experimental physiology.

[95]  A. Garfinkel,et al.  Preventing ventricular fibrillation by flattening cardiac restitution. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[96]  B. Olshansky,et al.  Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation , 2011, Heart Failure Reviews.

[97]  T. Gray,et al.  Nitric oxide and carbon monoxide synthesizing enzymes and soluble guanylyl cyclase within neurons of adult human cardiac ganglia , 2009, Autonomic Neuroscience.

[98]  R. Hershberger,et al.  Effect of Vasoactive Intestinal Peptide on Myocardial Contractility and Coronary Blood Flow in the Dog: Comparison with Isoproterenol and Forskolin , 1988, Journal of cardiovascular pharmacology.

[99]  S. Chugh,et al.  Sudden cardiac death with apparently normal heart. , 2000, Circulation.

[100]  W. C. Randall,et al.  Selective vagal innervation of sinoatrial and atrioventricular nodes in canine heart. , 1986, The American journal of physiology.

[101]  M. Beckmann,et al.  [Inflammation of the myocardium as an arrhythmia trigger]. , 2000, Zeitschrift fur Kardiologie.

[102]  D. Zipes,et al.  Effects of Sympathetic and Vagal Nerves on Recovery Properties of the Endocardium and Epicardium of the Canine Left Ventricle , 1980, Circulation research.

[103]  D. Schulze,et al.  Muscarinic Modulation of the Sodium-Calcium Exchanger in Heart Failure , 2007, Circulation.

[104]  J. Brown,et al.  Acetylcholine release from rat atria can be regulated through an alpha 1-adrenergic receptor. , 1985, Circulation research.

[105]  J. A. Armour,et al.  Potential clinical relevance of the ‘little brain’ on the mammalian heart , 2008, Experimental physiology.

[106]  H. Bruck,et al.  Presence, distribution and physiological function of adrenergic and muscarinic receptor subtypes in the human heart , 2001, Basic Research in Cardiology.

[107]  Peter J. Schwartz,et al.  Vagus nerve stimulation: from pre-clinical to clinical application: challenges and future directions , 2011, Heart Failure Reviews.

[108]  M. Josephson,et al.  Termination of Ventricular Tachycardia with Ventricular Stimulation: Salutary Effect of Increased Current Strength , 1982, Circulation.

[109]  Philip J Podrid,et al.  Epidemiology and stratification of risk for sudden cardiac death , 2005, Clinical cardiology.

[110]  J. Miller,et al.  Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. , 1987, The American journal of cardiology.

[111]  Chao Wang,et al.  Activation of cardiac M3 muscarinic acetylcholine receptors has cardioprotective effects against ischaemia‐induced arrhythmias , 2012, Clinical and experimental pharmacology & physiology.

[112]  S. S. Hull,et al.  Vagal stimulation and prevention of sudden death in conscious dogs with a healed myocardial infarction. , 1991, Circulation research.

[113]  E. Muscholl Peripheral muscarinic control of norepinephrine release in the cardiovascular system. , 1980, The American journal of physiology.

[114]  M. N. Levy,et al.  Sympathetic stimulation-evoked overflow of norepinephrine and neuropeptide Y from the heart. , 1991, Circulation research.

[115]  Takeshi Tsutsumi,et al.  Classification of antiarrhythmic drugs based on ventricular fibrillation threshold. , 1989, The American journal of cardiology.

[116]  A. Karma Electrical alternans and spiral wave breakup in cardiac tissue. , 1994, Chaos.

[117]  P. Schwartz,et al.  Autonomic mechanisms and sudden death. New insights from analysis of baroreceptor reflexes in conscious dogs with and without a myocardial infarction. , 1988, Circulation.

[118]  J. Armour Instant to Instant Reflex Cardiac Regulation , 1976 .

[119]  D. Rosenbaum,et al.  Modulated dispersion explains changes in arrhythmia vulnerability during premature stimulation of the heart. , 1998, Circulation.

[120]  R. Helfant,et al.  Electrophysiology underlying ventricular arrhythmias due to coronary ligation. , 1970, The American journal of physiology.

[121]  J. Lauenstein,et al.  Parasympathetic control of the heart. I. An interventriculo-septal ganglion is the major source of the vagal intracardiac innervation of the ventricles. , 2004, Journal of applied physiology.

[122]  A. Pearlman,et al.  Beneficial Effects of Vagal Stimulation and Bradycardia During Experimental Acute Myocardial Ischemia , 1974, Circulation.

[123]  I. Zucker,et al.  Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide. , 1999, Journal of applied physiology.

[124]  Masaru Sugimachi,et al.  Vagal Nerve Stimulation Markedly Improves Long-Term Survival After Chronic Heart Failure in Rats , 2003, Circulation.

[125]  B. Singh,et al.  Arrhythmia control by prolonging repolarization: the concept and its potential therapeutic impact. , 1993, European heart journal.

[126]  K. Minneman,et al.  Interaction of neuronal nitric oxide synthase with alpha1-adrenergic receptor subtypes in transfected HEK-293 cells , 2002, BMC pharmacology.

[127]  Mark T. Gladwin,et al.  The nitrate–nitrite–nitric oxide pathway in physiology and therapeutics , 2008, Nature Reviews Drug Discovery.

[128]  J S Floras,et al.  Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities. , 2003, Acta physiologica Scandinavica.

[129]  J. Bigger,et al.  Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction , 1998, The Lancet.

[130]  S. Ellis,et al.  Inhibitory effect of acetylcholine on glycogenolysis in the isolated guinea-pig heart. , 1963, The Journal of pharmacology and experimental therapeutics.

[131]  E. Angelakos Regional Distribution of Catecholamines in the Dog Heart , 1965, Circulation research.

[132]  J. Armour,et al.  Ventricular arrhythmias induced by chemically modified intrinsic cardiac neurones. , 1994, Cardiovascular research.

[133]  H. Critchley,et al.  Heart–brain interactions in cardiac arrhythmia , 2011, Heart.

[134]  T. Seeman,et al.  RR Interval Variability Is Inversely Related to Inflammatory Markers: The CARDIA Study , 2007, Molecular medicine.

[135]  M D Gershon The enteric nervous system. , 1981, Annual review of neuroscience.

[136]  Brian Olshansky,et al.  Parasympathetic nervous system and heart failure: pathophysiology and potential implications for therapy. , 2008, Circulation.

[137]  R. Verrier,et al.  The Effect of Vagus Nerve Stimulation upon Vulnerability of the Canine Ventricle: Role of Sympathetic‐Parasympathetic Interactions , 1975, Circulation.

[138]  R. Prescott,et al.  Prospective study of heart rate variability and mortality in chronic heart failure: results of the United Kingdom heart failure evaluation and assessment of risk trial (UK-heart). , 1998, Circulation.

[139]  Hani N. Sabbah,et al.  Electrical vagus nerve stimulation for the treatment of chronic heart failure , 2011, Cleveland Clinic Journal of Medicine.

[140]  S. Pogwizd,et al.  Connexin 43 Downregulation and Dephosphorylation in Nonischemic Heart Failure Is Associated With Enhanced Colocalized Protein Phosphatase Type 2A , 2004, Circulation research.

[141]  A. Kadish,et al.  Quantitative analysis of parasympathetic innervation of the porcine heart. , 2010, Heart rhythm.

[142]  F. Murad,et al.  Adenyl cyclase. III. The effect of catecholamines and choline esters on the formation of adenosine 3',5'-phosphate by preparations from cardiac muscle and liver. , 1962, The Journal of biological chemistry.

[143]  H. L. Stone,et al.  Baroreceptor Reflex Control of Heart Rate: A Predictor of Sudden Cardiac Death , 1982, Circulation.

[144]  E. Braunwald,et al.  Parasympathetic control of the heart. , 1973, Pharmacological reviews.

[145]  L. Tavazzi Heart rate as a therapeutic target in heart failure , 2003 .

[146]  Yanjie Lu,et al.  Function of cardiac M3 receptors. , 2007, Autonomic & autacoid pharmacology.

[147]  Kevin J. Tracey,et al.  Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation , 2002, Nature.